Aurinia Pharmaceuticals (AUPH) had the highest return between March 3, 2017 and March 20, 2017 by a small-cap US stock, returning 86.8%.
| ASSET | DATE | % RETURN |
|---|---|---|
Aurinia Pharmaceuticals (AUPH) | 3/3/2017 - 3/20/2017 | 86.81% |
TSS, Inc Common Stock (TSSI) | 3/3/2017 - 3/20/2017 | 73.64% |
Microvision (MVIS) | 3/3/2017 - 3/20/2017 | 68.83% |
Clearpoint Neuro (CLPT) | 3/3/2017 - 3/20/2017 | 60% |
Pulse Biosciences (PLSE) | 3/3/2017 - 3/20/2017 | 57.63% |
Corvus Pharmaceuticals (CRVS) | 3/3/2017 - 3/20/2017 | 52% |
Nektar Therapeutics (NKTR) | 3/3/2017 - 3/20/2017 | 49.09% |
Verastem (VSTM) | 3/3/2017 - 3/20/2017 | 42.11% |
Esperion Therapeutics (ESPR) | 3/3/2017 - 3/20/2017 | 37.4% |
Hello (MOMO) | 3/3/2017 - 3/20/2017 | 30.23% |
CytomX Therapeutics (CTMX) | 3/3/2017 - 3/20/2017 | 30.1% |
Spyre Therapeutics (SYRE) | 3/3/2017 - 3/20/2017 | 29.94% |
United States Antimony (UAMY) | 3/3/2017 - 3/20/2017 | 28.95% |
Arbutus Biopharma (ABUS) | 3/3/2017 - 3/20/2017 | 28.85% |
Lincoln Educational Services (LINC) | 3/3/2017 - 3/20/2017 | 27.49% |
Galectin Therapeutics (GALT) | 3/3/2017 - 3/20/2017 | 26.35% |
Maui Land & Pineapple (MLP) | 3/3/2017 - 3/20/2017 | 24.47% |
Astria Therapeutics (ATXS) | 3/3/2017 - 3/20/2017 | 23.93% |
BioCryst Pharmaceuticals (BCRX) | 3/3/2017 - 3/20/2017 | 23.66% |
Himax Technologies (HIMX) | 3/3/2017 - 3/20/2017 | 23.43% |
Assembly Biosciences (ASMB) | 3/3/2017 - 3/20/2017 | 22.13% |
Regenxbio (RGNX) | 3/3/2017 - 3/20/2017 | 21.72% |
Safe Bulkers (SB) | 3/3/2017 - 3/20/2017 | 20.78% |
PowerFleet (AIOT) | 3/3/2017 - 3/20/2017 | 20.69% |
AnaptysBio (ANAB) | 3/3/2017 - 3/20/2017 | 19.09% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
